PL2701716T3 - Hydrolizaty białkowe jako środki do przezwyciężania uzależnień - Google Patents
Hydrolizaty białkowe jako środki do przezwyciężania uzależnieńInfo
- Publication number
- PL2701716T3 PL2701716T3 PL12717282T PL12717282T PL2701716T3 PL 2701716 T3 PL2701716 T3 PL 2701716T3 PL 12717282 T PL12717282 T PL 12717282T PL 12717282 T PL12717282 T PL 12717282T PL 2701716 T3 PL2701716 T3 PL 2701716T3
- Authority
- PL
- Poland
- Prior art keywords
- agents
- protein hydrolysates
- addiction
- overcoming
- overcoming addiction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Business, Economics & Management (AREA)
- Entrepreneurship & Innovation (AREA)
- Physics & Mathematics (AREA)
- Educational Administration (AREA)
- Educational Technology (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11164063 | 2011-04-28 | ||
| EP12717282.3A EP2701716B1 (en) | 2011-04-28 | 2012-04-26 | Protein hydrolysates as agents for overcoming addiction |
| PCT/EP2012/057638 WO2012146651A1 (en) | 2011-04-28 | 2012-04-26 | Protein hydrolysates as agents for overcoming addiction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2701716T3 true PL2701716T3 (pl) | 2018-02-28 |
Family
ID=44263161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12717282T PL2701716T3 (pl) | 2011-04-28 | 2012-04-26 | Hydrolizaty białkowe jako środki do przezwyciężania uzależnień |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140050715A1 (pl) |
| EP (1) | EP2701716B1 (pl) |
| ES (1) | ES2651638T3 (pl) |
| PL (1) | PL2701716T3 (pl) |
| WO (1) | WO2012146651A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2382910T3 (es) | 2006-11-02 | 2012-06-14 | Dsm Ip Assets B.V. | Uso de hidrolizados de lisozima que contienen triptófano |
| PL2701716T3 (pl) | 2011-04-28 | 2018-02-28 | Dsm Ip Assets B.V. | Hydrolizaty białkowe jako środki do przezwyciężania uzależnień |
| EP2615470A1 (en) * | 2012-01-12 | 2013-07-17 | Koninklijke Philips Electronics N.V. | MR imaging with B1 mapping |
| NL2022627B1 (en) * | 2019-02-22 | 2020-08-31 | Newtricious Bv | Lysozyme hydrolysate for proactive inhibitory control and for attention |
| EP4033149A1 (en) | 2021-01-22 | 2022-07-27 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Monitoring combustible matter in a gaseous stream |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100796853B1 (ko) | 2000-12-06 | 2008-01-22 | 캄피나 쥐벨 베.붸. | 과량 트립토판 함유 펩티드의 제조방법 |
| WO2004069265A1 (en) | 2003-02-07 | 2004-08-19 | Campina B.V. | Use of tryptophan rich peptides |
| US7064104B2 (en) | 2003-06-13 | 2006-06-20 | The Procter & Gamble Company | Methods of managing the symptoms of premenstrual syndrome |
| US20050089546A1 (en) | 2003-09-16 | 2005-04-28 | Dick Wurtman | Compositions and methods comprising complex carbohydrate and alpha-lactalbumin |
| GB0326477D0 (en) | 2003-11-13 | 2003-12-17 | Shs Int Ltd | Medicaments for use in promoting and maintaining abstinence |
| CN1968691B (zh) | 2004-04-19 | 2010-12-29 | 麒麟麦酒株式会社 | 用于通过葡糖异生作用加速酒精代谢或从疲劳恢复的组合物 |
| EP1685764A1 (en) | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Anti-hypertensive functional food products |
| CN101535494B (zh) | 2006-11-02 | 2014-04-09 | 帝斯曼知识产权资产管理有限公司 | 含有色氨酸的肽 |
| ES2382910T3 (es) | 2006-11-02 | 2012-06-14 | Dsm Ip Assets B.V. | Uso de hidrolizados de lisozima que contienen triptófano |
| CN102076222B (zh) | 2008-04-29 | 2014-04-09 | 帝斯曼知识产权资产管理有限公司 | 包含碳水化合物和含色氨酸的肽的组合物 |
| KR101698216B1 (ko) | 2008-04-29 | 2017-01-19 | 디에스엠 아이피 어셋츠 비.브이. | 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물 |
| CN103153326B (zh) | 2010-10-05 | 2015-08-19 | 帝斯曼知识产权资产管理有限公司 | 含有色氨酸的肽 |
| PL2701716T3 (pl) | 2011-04-28 | 2018-02-28 | Dsm Ip Assets B.V. | Hydrolizaty białkowe jako środki do przezwyciężania uzależnień |
| CN104334037B (zh) * | 2012-11-02 | 2019-02-22 | 帝斯曼知识产权资产管理有限公司 | 富含色氨酸的蛋白水解产物的用途 |
-
2012
- 2012-04-26 PL PL12717282T patent/PL2701716T3/pl unknown
- 2012-04-26 EP EP12717282.3A patent/EP2701716B1/en active Active
- 2012-04-26 ES ES12717282.3T patent/ES2651638T3/es active Active
- 2012-04-26 US US14/114,466 patent/US20140050715A1/en not_active Abandoned
- 2012-04-26 WO PCT/EP2012/057638 patent/WO2012146651A1/en not_active Ceased
-
2016
- 2016-12-13 US US15/377,188 patent/US10668133B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2701716A1 (en) | 2014-03-05 |
| US20140050715A1 (en) | 2014-02-20 |
| US20170087226A1 (en) | 2017-03-30 |
| EP2701716B1 (en) | 2017-11-01 |
| ES2651638T3 (es) | 2018-01-29 |
| WO2012146651A1 (en) | 2012-11-01 |
| US10668133B2 (en) | 2020-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL227514A (en) | Rebaudioside – Mugroside mixture v | |
| GB201103955D0 (en) | Antibodies | |
| GB201107849D0 (en) | Cooperative positioning | |
| GB201112056D0 (en) | Antibodies | |
| ZA201308255B (en) | Albumin variants | |
| IL232743A0 (en) | anticancer fusion protein | |
| PL2474441T3 (pl) | Podstawka samochodowa | |
| IL228438A0 (en) | New methods for protein purification | |
| GB201113811D0 (en) | Protein recovery | |
| EP2765920A4 (en) | CUFF CONNECTORS | |
| PL2699674T3 (pl) | Syntetyczne warianty fitazy | |
| GB201111183D0 (en) | Peptide | |
| SG10201606218WA (en) | Purified Proteins | |
| GB201115910D0 (en) | Peptides | |
| PL2701716T3 (pl) | Hydrolizaty białkowe jako środki do przezwyciężania uzależnień | |
| GB201107468D0 (en) | Protein expression systems | |
| ZA201307011B (en) | Engine | |
| HUP1200319A2 (en) | Starter | |
| EP2714074A4 (en) | ANTIBODIES AGAINST EMR1 | |
| IL232029A0 (en) | Mirror | |
| GB2496056B (en) | Surround Trim | |
| GB201101794D0 (en) | Protein production | |
| GB201113089D0 (en) | Protein hydrolysates | |
| GB201103169D0 (en) | Protein expression | |
| HUP1100282A2 (en) | Protein factor |